Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Role of Toll-like receptors in gastrointestinal malignancies

Abstract

Mounting evidence supports the tenet that innate immune responses to luminal microbes participate in the development of gastrointestinal malignancies. The gastrointestinal tract is relatively unique in that it has evolved in the presence of diverse enteric microflora. Intestinal flora is required to develop a normal adaptive immune response in the periphery. With the characterization of the innate immune system, we have begun to understand the adaptations the intestine has made to the microbiota. The interaction between the microbiota and the intestinal mucosa through Toll-like receptors (TLRs) is required to maintain intestinal homeostasis. In particular, intestinal epithelial cells and lamina propria mononuclear cells such as antigen-presenting cells and T cells must respond to breaches in the mucosal barrier by activating TLR-dependent pathways that result in increased epithelial proliferation, wound healing and recruitment of acute inflammatory cells. In the setting of chronic inflammation such as Helicobacter pylori (H. pylori) infection in the stomach or idiopathic inflammatory bowel disease, the process of repair may eventually result in carcinogenesis. The following review highlights human and animal data that support a role for innate immune responses and TLRs specifically in promoting gastrointestinal malignancies. Candidate pathways linking TLRs to gastrointestinal malignancies include activation of nuclear factor-κB and cyclooxygenase-2. Studying the link between innate immune signaling and gastrointestinal malignancies offers the possibility to identify novel ways to both prevent and treat gastrointestinal cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Abreu MT, Fukata M, Arditi M . (2005). TLR signaling in the gut in health and disease. J Immunol 174: 4453–4460.

    CAS  PubMed  Google Scholar 

  • Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M . (2001). Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609–1616.

    CAS  PubMed  Google Scholar 

  • Arber N, Eagle CJ, Spicak J, Racz I, Dite P, Hajer J et al. (2006). Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355: 885–895.

    CAS  PubMed  Google Scholar 

  • Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E . (2004). Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172: 2522–2529.

    CAS  PubMed  Google Scholar 

  • Atherfold PA, Jankowski JA . (2006). Molecular biology of Barrett's cancer. Best Pract Res Clin Gastroenterol 20: 813–827.

    CAS  PubMed  Google Scholar 

  • Balkwill F, Coussens LM . (2004). Cancer: an inflammatory link. Nature 431: 405–406.

    CAS  PubMed  Google Scholar 

  • Baoprasertkul P, Peatman E, Abernathy J, Liu Z . (2007). Structural characterisation and expression analysis of Toll-like receptor 2 gene from catfish. Fish Shellfish Immunol 22: 418–426.

    CAS  PubMed  Google Scholar 

  • Bernstein CN, Eaden J, Steinhart AH, Munkholm P, Gordon PH . (2002). Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 8: 356–361.

    PubMed  Google Scholar 

  • Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K et al. (2006). Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355: 873–884.

    Article  CAS  PubMed  Google Scholar 

  • Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, Peruzovic M et al. (2006). Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin Genet 70: 156–160.

    CAS  PubMed  Google Scholar 

  • Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J et al. (2005). The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis 11: 645–652.

    PubMed  Google Scholar 

  • Brittan M, Wright NA . (2002). Gastrointestinal stem cells. J Pathol 197: 492–509.

    PubMed  Google Scholar 

  • Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, Stenson WF et al. (2007). Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 117: 258–269.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cario E, Podolsky DK . (2000). Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010–7017.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chamaillard M, Girardin SE, Viala J, Philpott DJ . (2003). Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 5: 581–592.

    CAS  PubMed  Google Scholar 

  • Chang YJ, Wu MS, Lin JT, Sheu BS, Muta T, Inoue H et al. (2004). Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol Pharmacol 66: 1465–1477.

    CAS  PubMed  Google Scholar 

  • Choi PM, Zelig MP . (1994). Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35: 950–954.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chung YC, Chang YF . (2003). Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 83: 222–226.

    PubMed  Google Scholar 

  • Contasta I, Pellegrini P, Berghella AM, Del Beato T, Adorno D . (2006). Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy. Cancer Biother Radiopharm 21: 488–505.

    CAS  PubMed  Google Scholar 

  • Coussens LM, Werb Z . (2002). Inflammation and cancer. Nature 420: 860–867.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Derdak Z, Fulop P, Sabo E, Tavares R, Berthiaume EP, Resnick MB et al. (2006). Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-kappaB activation and oxidative stress. Carcinogenesis 27: 956–961.

    CAS  PubMed  Google Scholar 

  • de Visser KE, Coussens LM . (2005). The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother 54: 1143–1152.

    CAS  PubMed  Google Scholar 

  • De Vita F, Romano C, Orditura M, Galizia G, Martinelli E, Lieto E et al. (2001). Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res 21: 45–52.

    CAS  PubMed  Google Scholar 

  • Dove WF, Clipson L, Gould KA, Luongo C, Marshall DJ, Moser AR et al. (1997). Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res 57: 812–814.

    CAS  PubMed  Google Scholar 

  • Drewitz DJ, Sampliner RE, Garewal HS . (1997). The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92: 212–215.

    CAS  PubMed  Google Scholar 

  • Du X, Poltorak A, Wei Y, Beutler B . (2000). Three novel mammalian Toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 11: 362–371.

    CAS  PubMed  Google Scholar 

  • Eaden JA, Abrams KR, Mayberry JF . (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526–535.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ekbom A, Helmick C, Zack M, Adami HO . (1990). Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336: 357–359.

    CAS  PubMed  Google Scholar 

  • Engle SJ, Ormsby I, Pawlowski S, Boivin GP, Croft J, Balish E et al. (2002). Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 62: 6362–6366.

    CAS  PubMed  Google Scholar 

  • Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B et al. (2003). CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162: 691–702.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Farinha P, Gascoyne RD . (2005). Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 23: 6370–6378.

    CAS  PubMed  Google Scholar 

  • Fass R, Hell RW, Garewal HS, Martinez P, Pulliam G, Wendel C et al. (2001). Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 48: 310–313.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R . (2001). Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42: 1337–1348.

    CAS  PubMed  Google Scholar 

  • Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T et al. (2004). Deficient host–bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987–992.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P et al. (2004). Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 10: 4015–4021.

    CAS  PubMed  Google Scholar 

  • Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS et al. (2006). Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862–877.

    CAS  PubMed  Google Scholar 

  • Fukata M, Chen A, Vamadevan AS, Choen J, Breglio K, Krishnareddy S et al. (2007). Toll-like receptor-4 (TLR4) promotes the development of colitis-associated colorectal tumors. Gastroenterology (in press).

  • Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K et al. (2005). Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288: G1055–G1065.

    CAS  PubMed  Google Scholar 

  • Fukumoto S, Ichihara T, Takada M, Kuroda Y . (2003). Expression of cyclooxygenases in Helicobacter pylori gastritis and residual gastritis after distal gastrectomy. World J Surg 27: 145–148.

    PubMed  Google Scholar 

  • Furrie E, Macfarlane S, Thomson G, Macfarlane GT . (2005). Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115: 565–574.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH et al. (1997). Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89: 1277–1284.

    CAS  PubMed  Google Scholar 

  • Garlanda C, Riva F, Veliz T, Polentarutti N, Pasqualini F, Radaelli E et al. (2007). Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res 67: 6017–6021.

    CAS  PubMed  Google Scholar 

  • Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A et al. (2005). Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11: 681–685.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285–296.

    CAS  PubMed  Google Scholar 

  • Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N . (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15: 1126–1131.

    CAS  PubMed  Google Scholar 

  • Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A et al. (2007). Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133: 1099–1105.

    PubMed  Google Scholar 

  • Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC et al. (1988). Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 29: 206–217.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Haselkorn T, Whittemore AS, Lilienfeld DE . (2005). Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 16: 781–787.

    PubMed  Google Scholar 

  • Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T et al. (2002). Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122: 1987–2000.

    CAS  PubMed  Google Scholar 

  • Helzlsouer KJ, Erlinger TP, Platz EA . (2006). C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 42: 704–707.

    CAS  PubMed  Google Scholar 

  • Hill MJ, Drasar BS, Hawksworth G, Aries V, Crowther JS, Williams RE . (1971). Bacteria and aetiology of cancer of large bowel. Lancet 1: 95–100.

    CAS  PubMed  Google Scholar 

  • Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA et al. (2007). A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132: 905–912.

    CAS  PubMed  Google Scholar 

  • Hope ME, Hold GL, Kain R, El-Omar EM . (2005). Sporadic colorectal cancer – role of the commensal microbiota. FEMS Microbiol Lett 244: 1–7.

    CAS  PubMed  Google Scholar 

  • Houghton J, Wang TC . (2005). Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128: 1567–1578.

    CAS  PubMed  Google Scholar 

  • Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH et al. (2005). Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65: 5009–5014.

    CAS  PubMed  Google Scholar 

  • Huang B, Zhao J, Shen S, Li H, He KL, Shen GX et al. (2007). Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 67: 4346–4352.

    CAS  PubMed  Google Scholar 

  • Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599–603.

    CAS  PubMed  Google Scholar 

  • Ishida I, Kubo H, Suzuki S, Suzuki T, Akashi S, Inoue K et al. (2002). Hypoxia diminishes Toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells. J Immunol 169: 2069–2075.

    CAS  PubMed  Google Scholar 

  • Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N et al. (2004). Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 173: 1406–1416.

    CAS  PubMed  Google Scholar 

  • Itzkowitz SH, Harpaz N . (2004). Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126: 1634–1648.

    PubMed  Google Scholar 

  • Itzkowitz SH, Yio X . (2004). Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7–G17.

    CAS  PubMed  Google Scholar 

  • Janne PA, Mayer RJ . (2000). Chemoprevention of colorectal cancer. N Engl J Med 342: 1960–1968.

    CAS  PubMed  Google Scholar 

  • Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M et al. (2001). Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res 61: 2395–2398.

    CAS  PubMed  Google Scholar 

  • Kawahara T, Kuwano Y, Teshima-Kondo S, Kawai T, Nikawa T, Kishi K et al. (2001a). Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 48: 190–197.

    CAS  PubMed  Google Scholar 

  • Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K . (2001b). Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69: 4382–4389.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kelly IM, Bartram CI . (1993). Pseudotumoral appearance of small bowel strictureplasty for Crohn's disease. Abdom Imaging 18: 366–368.

    CAS  PubMed  Google Scholar 

  • Kinoshita T, Ito H, Miki C . (1999). Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 85: 2526–2531.

    CAS  PubMed  Google Scholar 

  • Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y et al. (1996). Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307–317.

    CAS  PubMed  Google Scholar 

  • Langholz E, Munkholm P, Davidsen M, Binder V . (1992). Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103: 1444–1451.

    CAS  PubMed  Google Scholar 

  • Laqueur GL, Matsumoto H, Yamamoto RS . (1981). Comparison of the carcinogenicity of methylazoxymethanol-beta-D-glucosiduronic acid in conventional and germfree Sprague–Dawley rats. J Natl Cancer Inst 67: 1053–1055.

    CAS  PubMed  Google Scholar 

  • Leblond CP . (1964). Classification of cell populations on the basis of their proliferative behavior. Natl Cancer Inst Monogr 14: 119–150.

    CAS  PubMed  Google Scholar 

  • Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A et al. (2005). Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a−/− mice results in colitis that progresses to dysplasia. Am J Pathol 166: 1793–1806.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG et al. (2004). Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect Immun 72: 6446–6454.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Manju V, Nalini N . (2006). Effect of ginger on bacterial enzymes in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Eur J Cancer Prev 15: 377–383.

    CAS  PubMed  Google Scholar 

  • Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S et al. (2005). ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6: 587–592.

    CAS  PubMed  Google Scholar 

  • Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS et al. (2003). Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host–microbial interactions in the gut. J Immunol 170: 1406–1415.

    CAS  PubMed  Google Scholar 

  • Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR . (2001). Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 32: 449–453.

    CAS  PubMed  Google Scholar 

  • Nowacki MR . (1993). Cell proliferation in colonic crypts of germ-free and conventional mice – preliminary report. Folia Histochem Cytobiol 31: 77–81.

    CAS  PubMed  Google Scholar 

  • Ohara T, Morishita T, Suzuki H, Hibi T . (2006). Heterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of Toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas. Int J Mol Med 18: 59–63.

    CAS  PubMed  Google Scholar 

  • Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM et al. (2005). Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 11: 567–575.

    PubMed  Google Scholar 

  • Otte JM, Cario E, Podolsky DK . (2004). Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054–1070.

    CAS  PubMed  Google Scholar 

  • Ouburg S, Mallant-Hent R, Crusius JB, van Bodegraven AA, Mulder CJ, Linskens R et al. (2005). The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut 54: 439–440.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS . (2004). Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 173: 3589–3593.

    CAS  PubMed  Google Scholar 

  • Parkin DM, Pisani P, Ferlay J . (1999). Global cancer statistics. CA Cancer J Clin 49: 33–64.

    CAS  PubMed  Google Scholar 

  • Paulsen JE, Knutsen H, Olstorn HB, Loberg EM, Alexander J . (2006). Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice. Int J Cancer 118: 540–546.

    CAS  PubMed  Google Scholar 

  • Peek Jr RM, Blaser MJ . (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28–37.

    CAS  PubMed  Google Scholar 

  • Peter S, Beglinger C . (2007). Helicobacter pylori and gastric cancer: the causal relationship. Digestion 75: 25–35.

    PubMed  Google Scholar 

  • Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P et al. (2006). Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12: 1–8.

    PubMed  Google Scholar 

  • Pomorski T, Meyer TF, Naumann M . (2001). Helicobacter pylori-induced prostaglandin E(2) synthesis involves activation of cytosolic phospholipase A(2) in epithelial cells. J Biol Chem 276: 804–810.

    CAS  PubMed  Google Scholar 

  • Potten CS, Booth C, Pritchard DM . (1997). The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 78: 219–243.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN et al. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359: 235–237.

    CAS  PubMed  Google Scholar 

  • Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS . (2005). Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 102: 99–104.

    CAS  PubMed  Google Scholar 

  • Rad R, Brenner L, Krug A, Voland P, Mages J, Lang R et al. (2007). Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 133: 150–163.

    CAS  PubMed  Google Scholar 

  • Rakoff-Nahoum S, Medzhitov R . (2007). Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124–127.

    CAS  PubMed  Google Scholar 

  • Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R . (2004). Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229–241.

    CAS  PubMed  Google Scholar 

  • Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS . (2002). Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62: 165–170.

    CAS  PubMed  Google Scholar 

  • Reddy BS, Narisawa T, Wright P, Vukusich D, Weisburger JH, Wynder EL . (1975). Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 35: 287–290.

    CAS  PubMed  Google Scholar 

  • Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF . (1998). A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95: 588–593.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P et al. (1998). Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 273: 28560–28563.

    CAS  PubMed  Google Scholar 

  • Rumio C, Besusso D, Arnaboldi F, Palazzo M, Selleri S, Gariboldi S et al. (2006). Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol 208: 47–54.

    CAS  PubMed  Google Scholar 

  • Rumio C, Besusso D, Palazzo M, Selleri S, Sfondrini L, Dubini F et al. (2004). Degranulation of paneth cells via Toll-like receptor 9. Am J Pathol 165: 373–381.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M et al. (2004). Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126: 451–459.

    PubMed  Google Scholar 

  • Sawaoka H, Kawano S, Tsuji S, Tsuji M, Sun W, Gunawan ES et al. (1998). Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot Essent Fatty Acids 59: 313–316.

    CAS  PubMed  Google Scholar 

  • Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Muller-Hermelink HK et al. (2004). Expression and subcellular distribution of Toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 136: 521–526.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M . (2005). Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 295: 179–185.

    CAS  PubMed  Google Scholar 

  • Schultz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, Kwon J et al. (1999). IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 276: G1461–G1472.

    CAS  PubMed  Google Scholar 

  • Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E et al. (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224–5231.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sigel JE, Petras RE, Lashner BA, Fazio VW, Goldblum JR . (1999). Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol 23: 651–655.

    CAS  PubMed  Google Scholar 

  • Spechler SJ . (1999). The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 117: 218–228.

    CAS  PubMed  Google Scholar 

  • Stolte M, Eidt S . (1989). Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol 42: 1269–1271.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C et al. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668–670.

    CAS  PubMed  Google Scholar 

  • Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK et al. (2000). Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157: 729–735.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Suzuki M, Hisamatsu T, Podolsky DK . (2003). Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4–MD-2 complex. Infect Immun 71: 3503–3511.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T . (2006). Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 27: 162–169.

    CAS  PubMed  Google Scholar 

  • Suzuki R, Kohno H, Sugie S, Tanaka T . (2005). Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol Histopathol 20: 483–492.

    CAS  PubMed  Google Scholar 

  • Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J et al. (1998). Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115: 281–286.

    CAS  PubMed  Google Scholar 

  • Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R et al. (2004). Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93: 97–108.

    CAS  PubMed  Google Scholar 

  • Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C . (2004a). Crohn's disease is associated with a Toll-like receptor-9 polymorphism. Gastroenterology 127: 365–366.

    PubMed  Google Scholar 

  • Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C . (2004b). Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 112: 85–91.

    CAS  PubMed  Google Scholar 

  • Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP et al. (2004). Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5: 1166–1174.

    CAS  PubMed  Google Scholar 

  • Wang X, Huycke MM . (2007). Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132: 551–561.

    CAS  PubMed  Google Scholar 

  • Wyatt JI, Rathbone BJ . (1988). Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl 142: 44–49.

    CAS  PubMed  Google Scholar 

  • Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D et al. (2007). The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26: 461–475.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M T Abreu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukata, M., Abreu, M. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 27, 234–243 (2008). https://doi.org/10.1038/sj.onc.1210908

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210908

Keywords

This article is cited by

Search

Quick links